Literatur
Haubitz M, Schellong S, Göbel U et al (1998) Intravenous cyclophosphamide pulse administration versus daily oral treatment in patients with ANCA-associated vasculitis and renal involvement. Arthritis Rheumat 41:1835–1844
De Groot K, Harper L, Jayne DR et al (2009) Pulse versus daily oral cyclohosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med 150:670–680
Sanders JS, Slot MC, Stegeman CA (2003) Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349(21):2072–2073
Neumann I, Kain R, Regel H et al (2005) Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis. Nephrol Dial Transplant 20:96–104
Interessenkonflikt
Die korrespondierende Autorin gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Haubitz, M. Langzeitdaten der CYCLOPs-Studie. Z. Rheumatol. 72, 402–403 (2013). https://doi.org/10.1007/s00393-012-1125-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00393-012-1125-2